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Hemogenic endothelium (HE) has been recognized
as a source of hematopoietic stem cells (HSCs) in
the embryo. Access to human HE progenitors
(HEPs) is essential for enabling the investigation of
the molecular determinants of HSC specification.
Here, we show that HEPs capable of generating
definitive hematopoietic cells can be obtained
from human pluripotent stem cells (hPSCs) and iden-
tified precisely by a VE-cadherin+CD73CD235a/
CD43 phenotype. This phenotype discriminates
true HEPs from VE-cadherin+CD73+ non-HEPs and
VE-cadherin+CD235a+CD41a early hematopoietic
cells with endothelial and FGF2-dependent hemato-
poietic colony-forming potential. We found that
HEPs arise at the post-primitive-streak stage of
differentiation directly from VE-cadherin-negative
KDRbrightAPLNR+PDGFRalow/ hematovascular me-
sodermal precursors (HVMPs). In contrast, heman-
gioblasts, which are capable of forming endothelium
and primitive blood cells, originate from more
immature APLNR+PDGFRa+ mesoderm. The demar-
cation of HEPs and HVMPs provides a platform for
modeling blood development from endothelium
with a goal of facilitating the generation of HSCs
from hPSCs.INTRODUCTION
Establishing a system for de novo generation of hematopoietic
stem cells (HSCs) from human pluripotent stem cells (hPSCs)
would provide a unique opportunity to study human HSC devel-
opment and provide a novel source of therapeutic cells for blood
disease. Achieving this goal requires a detailed understanding of
the cellular and molecular pathways that lead to blood formationCelfrom hPSCs, and identification of the immediate precursors of
multipotential hematopoietic cells.
Avian, mouse, and human embryonic studies demonstrated
that definitive HSCs that give rise to all lineages of an adult hema-
topoietic system are generated in the aorta-gonad-meso-
nephros (AGM) region and are located at the ventral aspect of
the dorsal aorta (de Bruijn et al., 2002; Ivanovs et al., 2011; Par-
danaud et al., 1996; Taoudi and Medvinsky, 2007). In this area,
hematopoietic cells arise from a unique population of endothelial
cells known as hemogenic endothelium (HE) through an endo-
thelial-hematopoietic transition (EHT) (Boisset et al., 2010; Jaf-
fredo et al., 2000; Zovein et al., 2008). Dynamic tracing and
imaging studies conducted in vivo demonstrated that EHT repre-
sents a continuous process in which cells with endothelial char-
acteristics gradually acquire hematopoietic morphology and
phenotype (Bertrand et al., 2010; Boisset et al., 2010; Kissa
and Herbomel, 2010). Definitive hematopoiesis in the AGM
region is preceded by primitive hematopoiesis in the yolk sac,
which initially generates primitive erythrocytes, megakaryo-
cytes, and macrophages (Palis et al., 1999; Xu et al., 2001).
The second wave of yolk sac hematopoiesis, termed erythro-
myeloid hematopoiesis, is associated with an expansion of
erythroid precursors expressing adult b-globins and uni- and
multilineage myeloid precursors (Palis et al., 1999). Although
the concept of HE was developed based on observations of
blood formation within the aorta, it is also known that endothe-
lium lining nascent capillaries in the yolk sac (Ferkowicz et al.,
2003), and possibly vitelline and umbilical arteries (Yokomizo
and Dzierzak, 2010), has the capacity to generate blood as well.
The demonstrations of HSC formation from endothelium
emphasized the need to gain access to well-defined populations
of HE cells in hPSC cultures in order to develop technologies for
de novo generation of HSCs from human induced pluripotent
(hiPSCs) or embryonic stem cells (hESCs). In the embryo, defin-
itive HE can be identified based on anatomical location,
morphology, and expression of Runx1 (Jaffredo et al., 2010;
North et al., 1999, 2002). Because these criteria cannot be
entirely applied to cells differentiated in vitro, the precise identi-
fication of HE in hPSC cultures has remained a significantl Reports 2, 553–567, September 27, 2012 ª2012 The Authors 553
challenge. Although the VE-cadherin+CD41a or CD45 pheno-
type is commonly used for detection and isolation of HE, it has
very limited utility in human PSC cultures because it covers the
entire population of endothelial cells, does not fully exclude
hematopoietic cells, and does not discriminate between endo-
thelial lineageswith primitive and definitive hematopoietic poten-
tials. In addition, the direct mesodermal precursor of HE with
definitive hematopoietic potential remains largely unknown.
In this study, we show that HE progenitors (HEPs) can be
generated from hPSCs and identified precisely based on
VE-cadherin (CD144) expression and the lack of CD73 and
CD235a/CD43 expression. We demonstrate that HEPs repre-
sent a transient population of cells with the stroma-dependent
capacity to generate the entire spectrum of myeloid progenitors,
including b-hemoglobin-producing erythroid cells and pan-
myeloid colony-forming cells–granulocyte, erythrocyte, macro-
phage, megakaryocyte (CFC-GEMM). In addition, we found
that the earliest VE-cadherin+CD73CD43lowCD235a+CD41a
blood cells retain endothelial potential and possess a unique
FGF2-dependent hematopoietic colony-forming activity. A
population of endothelial progenitors lacking hematopoietic
potential (non-HEPs) was distinctively recognized by the
expression of CD73 and a high level of CD117, i.e., a
VE-cadherin+CD73+CD235a/CD43CD117high phenotype. VE-
cadherin+CD73CD235a/CD43 HE cells originated from VE-
cadherin-negative KDRbrightAPLNR+PDGFRalow/ hematovas-
cular mesodermal precursors (HVMPs), which were highly
enriched in cells forming hematoendothelial clusters on OP9
stromal cells. These progenitors were distinct from the more
primitive APLNR+PDGFRa+ mesoderm, which contains a popu-
lation of hemangioblasts (HBs) that have the capacity to form
colonies composed of primitive-type blood cells through endo-
thelial intermediates in serum-free semisolid medium.
RESULTS
Identification of Functionally Distinct Progenitors
with Hematopoietic and/or Endothelial Potential
within Emerging Embryonic VE-Cadherin+ Cells
Based on Expression of CD73 and CD235a
To characterize the development of various mesodermal line-
ages, we employed an hPSC differentiation system in coculture
with OP9 (Choi et al., 2009a; Vodyanik et al., 2006, 2010). In this
culture, we previously identified CD43 as a marker for hPSC-
derived progenitors that have the potential to form hematopoi-
etic cytokine-dependent colonies in semisolid medium, and
demonstrated that CD43 expression separates hematopoietic
cells from endothelial cells (Choi et al., 2009a; Vodyanik et al.,
2006). To investigate the developmental steps immediately
preceding the formation of CD43+ blood cells, andmap the point
of divergence of hematopoietic and endothelial cell lineages, we
analyzed the kinetic expression of various endothelial markers
following H1 hESC differentiation in OP9 coculture. The first cells
that expressed the VE-cadherin endothelial marker (Breier et al.,
1996) were detected by day 4 of differentiation (Figures 1A and
S1A). Upregulation of VE-cadherin expression on differentiated
hESCs in OP9 coculture coincided with the expression of
another endothelial marker, CD31 (PECAM) (Figure 1A). Of554 Cell Reports 2, 553–567, September 27, 2012 ª2012 The Authorinterest, cells expressing CD235a (Glycophorin A), a hematopoi-
etic marker of erythroid lineage, could be detected within the first
emerging VE-cadherin+ cells (Figure S1B). On the next day of
differentiation (day 5), the number of VE-cadherin+ cells and
the proportion of CD235a+ cells within this population substan-
tially increased. All of the VE-cadherin+CD235a+ cells were
negative for CD41a (abbreviated as V+235+41 cells) on day 4
of differentiation. However, on day 5 of differentiation, a small
proportion of CD235a+ cells coexpressing CD41a (V+235+41+
cells) could be detected (Figures 1B and S1B). Although
V+235+41+ cells expressed a high level of CD43, which indicates
hematopoietic commitment (Vodyanik et al., 2006), expression
of CD43 in V+235+41 cells was relatively low and was best
detectable with antibodies conjugated with APC or PE (Fig-
ure S1C). Thus, we combined CD235a and CD43 antibodies in
our studies to achieve optimal pan-hematopoietic detection at
all stages of differentiation.
A phenotypic analysis of day 5 VE-cadherin+ cells revealed
almost uniform expression of CD31, KDR, CD34, CD201,
ESAM, and CD146 endothelial markers by these cells. However,
we noticed that another typical endothelial marker, CD73 (or
50-nucleotidase; Thomson et al., 1990), was expressed only in
20%–60% of total VE-cadherin+ cells almost exclusively within
the 235a/CD43 population (Figures 1B, S1B, and S1D). This
observation led us to identify three distinct major subsets
within emerging VE-cadherin+ cells: V+235+41, V+73+, and
V+73235 (Figure 1B; Table 1). A kinetic analysis revealed
that V+73235cells represent a transient population that
develops during the earliest stages of endothelial commitment
but is mostly lost within the next 3 days of differentiation. The
V+73+ population was minor at the onset of endotheliogenesis
but gradually increased with advanced differentiation. The
proportion of VE-cadherin+ cells expressing 235a and/or CD43
hematopoietic markers peaked on day 5 of differentiation and
then decreased (Figure S1B).
As demonstrated in Figure 1B, all three major VE-cadherin+
cell subsets had very similar endothelial phenotypes and were
capable of acetylated low-density lipoprotein (AcLDL) uptake,
indicative of endothelial function. However, we noticed that
expression of CD117 (c-Kit), a marker for early-stage angiohe-
matopoietic progenitors, was highest in V+73+ cells, and its
expression was almost undetectable in V+235+41 cells.
V+73235 cells expressed an intermediate level of CD117
(Figure 1B). We also found that, in contrast to other day 5 VE-
cadherin+ subsets, V+73+ cells lacked the expression of CD226
(DNAM-1), a cell surface marker typically found on hematopoi-
etic cells (Kojima et al., 2003; Shibuya et al., 1996). Morpholog-
ically, the V+235+41 population consisted predominantly of
cells with a high nuclear/cytoplasmic ratio, which is typical for
immature hematopoietic cells. In contrast, almost all V+73+ cells
had a characteristic endothelial morphology. V+73235 cells
had an intermediate morphology resembling those of both
V+235+41 and V+73+ cells, i.e., pale blue cytoplasm similar to
endothelial cells, and a higher nuclear/cytoplasmic ratio similar
to immature hematopoietic cells (Figure 1B).
To fully analyze the differentiation potential of the newly
discovered VE-cadherin+ cell subsets, we isolated each one by
fluorescence-activated cell sorting (FACS), cultured it ins
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Figure 1. Characterization of Major Subsets of VE-Cadherin+ Cells Generated from hESCs after 5 Days of Coculture on OP9
(A) Kinetics of VE-cadherin and CD31 expression in differentiated H1 hESCs.
(B) Characterization of endothelial and hematopoietic CFC potentials of freshly isolated day 5 VE-cadherin+ subsets. Histograms represent the expression of
typical endothelial molecules by indicated cell subsets. AcLDL histograms show flow cytometric profiles of cells incubated with AcLDL at 37C (AcLDL uptake;
black histogram) versus 4C (AcLDL binding control; gray histogram). (i) Wright-stained cytospins demonstrate the morphology of isolated cells (bar = 20 mm).
Endothelial culture panels show (ii) phase-contrast images (bar = 400 mm), (iii) immunofluorescent analysis (bar = 100 mm), and (iv) tube formation (bar = 400 mm).
The hematopoietic CFC potential of sorted day 5 VE-cadherin+ subsets was evaluated in serum-free MethoCult (SF) supplemented with FGF2, SCF, IL6, IL3, and
EPO, and in standard serum-containing GF+ H4435 MethoCult. Error bars are means ± SE of three experiments.
See also Figures S1 and S3.
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Table 1. Phenotypic Features and Definition of Subsets with Endothelial and/or Hematopoietic Potential from hPSCs Analyzed and
Characterized in This Study
Abbreviation Phenotype Day of Isolationa Definition
V+73235 HEP VE-cadherin+CD73CD235a/
CD43CD117intermediate
5 Hemogenic endothelial progenitors that have primary
endothelial characteristics and lack hematopoietic
CFC potential and surface markers, but are capable of
generating blood and endothelial cells upon coculture
with stromal cells
V+73+ Non-HEP VE-cadherin+CD73+ CD235a/
CD43CD117high
5 Nonhemogenic endothelial progenitors that have all
of the functional and molecular features of endothelial
cells, and form endothelial colonies on OP9
V+235+41 AHP VE-cadherin+CD73CD43low
CD235a+CD41aCD117
5 Angiogenic hematopoietic progenitors that possess
primary hematopoietic characteristics and FGF2 and
hematopoietic cytokine-dependent colony-forming
potential in serum-free medium, but are capable of
generating endothelial cells
V+235+41+ EMkP VE-cadherin+CD73CD43+
CD235a+CD41a+
5 Hematopoietic cells that are enriched in
erythromegakaryocytic progenitors
MHP linCD34+CD43+CD45+CD38 8 Multipotential hematopoietic progenitors that lack
expression of lineage-specific hematopoietic markers
(lin) and form a full spectrum of myeloid colonies in
serum-containing semisolid medium supplemented
with hematopoietic cytokines
KbrA+P HVMP EMHlinKDRbrightAPLNR+
PDGFRalow/ b
4 Hematovascular mesodermal precursors that express
genes associated with lateral plate/extraembryonic
mesoderm and angiohematopoietic commitment, but
lack the expression of primitive streak genes. These
cells are highly enriched in bipotential cells that form
hematoendothelial clusters on OP9.
A+P+ PM EMHlinAPLNR+PDGFRa+ b 3 Primitive posterior mesoderm enriched in cells that
express a typical primitive streak and lateral plate/
extraembryonic mesoderm genes. These cells
have potential to form FGF2-dependent blast
(hemangioblast) colonies in serum-free medium.
a Day of isolation indicates the day of hPSC differentiation in coculture with OP9 on which the indicated cell subsets were optimally detected and iso-
lated from cultures.
b EMHlin denotes lack of expression of CD31, VE-cadherin endothelial, CD73 and CD105mesenchymal/endothelial cell markers, and CD43 and CD45
hematopoietic cell markers. See also Figure S2.endothelial conditions, and assayed it for hematopoietic colony-
forming activity (Figure S2). As shown in Figure 1B, the three
major day 5 VE-cadherin+ subsets (V+73235, V+235+41,
and V+73+ cells), but not the minor V+235+CD41+ subset, formed
a monolayer of adherent cells with endothelial morphology when
cultured on fibronectin in endothelial growthmedium. Consistent
with their endothelial nature, these cells expressed VE-cadherin,
took up AcLDL, and formed vascular tubes in Matrigel matrix. In
contrast, hematopoietic CFC potential was detected almost
exclusively within V+235+41 and V+235+41+ cells. Although
the hematopoietic CFC potential of V+235+41 cells in standard
serum-based CFC medium was low and mostly restricted to
small CFC-E, we found that the number and spectrum of hema-
topoietic CFCs were markedly increased in serum-free medium
containing FGF2, SCF, EPO, IL-3, and IL-6. In the serum-free
conditions, day 5 V+235+41 cells formed large erythroid, mega-
karyocyte, myeloid, and mixed colonies composed of erythroid
cells, macrophages, and megakaryocytes, indicating that
emerging blood cells expressing the CD235a erythroid marker556 Cell Reports 2, 553–567, September 27, 2012 ª2012 The Authorhad multilineage potential (Figures S3A and S3B). To define
which growth factors are required for V+235+41 cells to form
hematopoietic colonies, we eliminated each cytokine individually
from clonogenic cultures. These experiments demonstrated that
both FGF2 and EPO were essential for the development of large
CFC-E and CFC-Mix (Figure S3C). The removal of SCF almost
entirely abrogated CFC-Mix, but had little effect on large CFC-
E. Myeloid colonies required IL-3 and FGF2 for optimal develop-
ment. The day 5 V+235+41+ cells formed predominantly CFC-E
and CFC-Mix; however, they had downregulated expression of
APLNR and TEK, and failed to grow into endothelial cells in
endothelial conditions, indicating that the acquisition of CD41a
expression was associated with the complete loss of endothelial
potential (Figures 1B and S1D).
The hemogenic potential of embryonic endothelial cells can be
identified in culture with bone marrow stromal cells (Nishikawa
et al., 1998; Oberlin et al., 2002); thus, we cultured day 5 VE-
cadherin+ subsets on OP9 separately. In these conditions, both
V+73235 and V+235+41 cells generated CD31+CD43/45s
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Figure 2. Stroma-Dependent Hematopoietic and Endothelial Potential of Day 5 VE-Cadherin+ Subsets
(A) Phase-contrast images of cultures (bar = 400 mm), flow cytometric analysis and hematopoietic CFC potential (GF+ H4435 serum-containing MethoCult) are
shown. Error bars are means ± SE of three experiments. The numbers show mean counts for CFC-GEMM.
(B) A single-cell deposition assay to detect the frequency of endothelial, hematopoietic, and bipotential hematoendothelial progenitors. Immunofluorescent
staining of clusters formed by single cells after 10–12 days of culture on OP9 using CD43 and VE-cadherin antibodies is shown (bar = 100 mm). Graph shows the
frequency of each type of progenitor as a percentage of cluster-containingwells versus total cell-deposited wells. Error bars aremeans ±SE of three experiments.endothelial cells and a significant amount of CD43+ blood cells
(Figure 2A). TheCD43+ cells consisted of CD235a/CD41a+ eryth-
romegakaryocytic cells and CD235a/CD41aCD45+/ multipo-
tent hematopoietic progenitors (MHPs), which we typically
observe from hESCs differentiated on OP9 for 8–9 days (Vodya-Celnik et al., 2006). These day 8–9 CD235a/CD41aCD45+/ MHPs
express CD34 but lack CD38 and other hematopoietic lineage
markers, i.e., they have a linCD34+CD43+CD45+/CD38
phenotype (Vodyanik et al., 2006). Although both V+73235
and V+235+41 cells generated a broad range of hematopoieticl Reports 2, 553–567, September 27, 2012 ª2012 The Authors 557
colonies in standard serum-containingCFCmedium after culture
on OP9, the V+73235 cells formed a higher number of myeloid
colonies, including large multicentric pan-myeloid GEMM colo-
nies. In contrast, V+73+ cells formed mostly CD31+CD43/45
endothelial cells with very few hematopoietic cells (Figure 2A).
To determine the frequency of progenitors with hematopoietic
and endothelial potential in each day 5 VE-cadherin+ subset, we
performed a single-cell deposition assay. As shown in Figure 2B,
V+73+ single cells generated only endothelial clusters on OP9
with a frequency of approximately one in five, and V+235+41
cells formed predominantly hematopoietic cell clusters.
Although the majority of V+73235 cells gave rise to either
hematopoietic or endothelial clusters, 2.5% of them had the
potential to form hematoendothelial clusters, indicating the pres-
ence of bipotential progenitors within this population.
Based on the functional and phenotypical properties of
each VE-cadherin+ subset, we defined them as follows: (1)
V+73235 are HEPs that have primary endothelial characteris-
tics but lack hematopoietic CFC potential and surface markers,
express an intermediate level of CD117, and are capable of
generating blood and endothelial cells upon coculture with
stromal cells; (2) V+235+41 are angiogenic hematopoietic
progenitors (AHPs) that possess primary hematopoietic charac-
teristics but are capable of generating endothelial cells; and (3)
V+73+ are non-HEPs that have all the functional and molecular
features of endothelial cells, form endothelial colonies on OP9,
and express a high level of the early progenitor marker CD117
(see also Table 1).
Molecular profiling studies revealed a high similarity between
the day 5 VE-cadherin+ population subsets. All subpopulations
of these cells expressed the typical endothelial genes (TFP,
HIF1A, AAMP, F2R, EDF1, and PROCR) and the genes associ-
ated with angiohematopoietic and HSC development (FLI1,
TEK, LMO2, TAL1, RUNX1, CBFB, PBX1, PTEN, and TCEA1).
However, V+235+41 AHPs expressed higher levels of hemato-
poietic-specific genes and lower levels of the typical endothelial
(CAV1, CTGF, APOLD1, and AMOT) and endothelial junction
(CDH5, CDH2, and CLDN5) genes (Figure 3A). In contrast,
V+73235 HEPs expressed higher levels of the endothelial
genes CLDN5, CAV1, andMMRN1N, and lacked the expression
of hematopoietic genes. In comparison with the HEPs, the V+73+
non-HEPs expressed higher levels of the endothelial genes
EMCN, CAV1, CXCR4, CLDN5, and COL15A1 (Figure S4A).
Genes that were found to be more highly expressed in HEPs
versus non-HEPs included NTS neurotensin; BMPER, an endo-
thelial regulator that controls BMP4-dependent angiogenesis
(Heinke et al., 2008); and SMAD6, a negative regulator of BMP
signaling (Ishida et al., 2000) and RUNX1 activity (Knezevic
et al., 2011).
Hemogenic Endothelial Cells Originate from a Unique
EMHlin-KDRbrightAPLNR+PDGFRalow/ Population
of Mesodermal Cells with Hematovascular Potential
To identify the direct mesodermal precursor of HE cells, we
analyzed the expression of the mesodermal markers APLNR
(D’Aniello et al., 2009; Vodyanik et al., 2010), KDR (Shalaby
et al., 1997), and PDGFRa (CD140a) (Kataoka et al., 1997) in
differentiated hESCs before the first VE-cadherin+ cells could558 Cell Reports 2, 553–567, September 27, 2012 ª2012 The Authorbe detected. This analysis revealed the population of KDRbright
APLNR+ cells that was initially detected on day 3.5 of differenti-
ation (Figure 4A) immediately preceding the formation of the first
VE-cadherin+ cells in hESC/OP9 coculture (Figure 1A). Emerging
day 3.5 KDRbrightAPLNR+ cells essentially lacked the typical
CD31, VE-cadherin endothelial, CD73, CD105 mesenchymal/
endothelial, and CD43, CD45 hematopoietic cell markers
(hereafter referred to as EMHlin cells); however, the early
VE-cadherin+ cells became clearly detectable within this popula-
tion from day 4 of differentiation (Figure 4B). A flow cytometric
analysis of day 4 VE-cadherinKDRbrightAPLNR+ cells revealed
that they maintained the EMHlin phenotype (EMHlinKDRbright
APLNR+). However, in contrast to the more-primitive day 2 and
day 3 APLNR+ (Vodyanik et al., 2010) and day 4 KDRdim meso-
dermal cells, day 4 EMHlinKDRbrightAPLNR+ cells had downre-
gulated expression of PDGFRa (Figure 4B). Although these
day 4 EMHlinKDRbrightAPLNR+PDGFRalow/ (KbrA+P) cells
lacked the most specific endothelial markers, VE-cadherin and
CD31, they expressed other markers typically found on endothe-
lial cells, including TEK, CD34, CD201, and CD146 (Figures 4B
and S5A), suggesting that these mesodermal cells could be
direct precursors of endothelial progenitors in hESC cultures.
To confirm our hypothesis, we isolated day 4 KbrA+P, KDRdim,
and KDR cells using flow cytometry (Figure 4C) and cultured
them on OP9.
As shown in Figure 4C, after 5–6 days of culture on OP9,
only KbrA+P cells generated both CD31+CD43/45 endothe-
lial cells and CD43/CD45+ hematopoietic cells, whereas KDRdim
cells predominantly generated CD146+CD31 mesenchymal
cells, few endothelial cells, and almost no blood cells. KDR cells
lacked hematovascular potential completely. Of importance,
day 4 KbrA+P cells generated the V+73235, V+235+41, and
V+73+ subsets we observed on day 5 of primary hESC/OP9
coculture (Figure 4C). It should be also noted that KbrA+P cells
were multipotential and capable of differentiating into CD146+
CD31 mesenchymal cells in addition to blood and endothelial
cells (Figure 4C). Double staining of KbrA+P cells grown on
OP9 with VE-cadherin and CD43 antibodies revealed that they
formed HE clusters, i.e., sheets of endothelial cells generating
nonadherent blood cells (Figure 4D). Morphological examination
of HE clusters at different stages of development revealed that
endothelial cells within these clusters gradually transitioned
into hematopoietic cells. During the early stages of transition,
VE-cadherin+ cells had upregulated CD43 expression and trans-
formed from a cuboidal to a round cell morphology (Figure 4D;
Movie S1). Single-cell deposition experiments demonstrated
that KbrA+P cells formed HE clusters at a high frequency
(approximately one in 10 cells), strongly indicating that these
cells represent the direct precursors of HE (Figure 4E).
To confirm that KbrA+P cells are direct precursors of the
HEPs, we isolated these cells from day 3.5 of hESC/OP9
cocultures, before VE-cadherin+ cells became detectable (see
Figure 1A), and recultured them on OP9 for 2 days. A flow cyto-
metric analysis of these KbrA+P secondary cultures revealed
that they had upregulated VE-cadherin expression and differen-
tiated into the V+73235, V+235+41, and V+73+ subsets we
observed on day 5 of primary hESC/OP9 coculture (Figure S5B).
When we isolated these subsets from the secondary coculturess
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Figure 3. Gene Expression Profiling of Undifferentiated H1 hESCs, Differentiated H1 hESC Populations, and Human Umbilical Endothelial
Cells
(A) Heat maps of selected genes associated with endothelial and hematopoietic cells, EMT, lateral plate/EE mesoderm, and primitive streak. HB cores are
endothelial intermediates formed by HBs in serum-free clonogenic medium. The gene expression levels are estimated in transripts per million (tpm). EC p2,
second passage of endothelial cells obtained from day 8 CD31+CD43 differentiated H1 cells; EE, extraembryonic; EMT, epithelial-mesenchymal transition;
HUVEC, human umbilical vein endothelial cells. See Table 1 for other abbreviations.
(B) Pearson correlation analysis of global gene expression.
See also Figure S4.
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Figure 4. Phenotypic and Functional Characterization of Major Subsets of Day 4 hESC-Derived Mesodermal Cells
(A) Kinetics of expression of APLNR and KDR in differentiated H1 hESCs.
(B) Flow cytometric analysis of day 4 hESC-derived mesodermal cells that were first magnetically sorted for the KDR+ population.
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by FACS and analyzed them for endothelial and hematopoietic
potentials, we found that the V+73235, V+235+41, and
V+73+ cells generated from isolated day 3.5 KbrA+P cells had
the same hematopoietic and endothelial differentiation poten-
tials as the primary day 5 HEP, AHP, and non-HEP subsets,
respectively (Figure S5C).
Amorphologic analysis revealed that KbrA+P cells were large,
blast-like cells that were noticeably different from KDRdim and
KDR cells, which had a more abundant and vacuolated cyto-
plasm (Figure 4C). Molecular profiling studies revealed that in
KbrA+P cells, expression of transcriptional regulators of hema-
topoietic and endothelial development (LMO2, TAL1, CBFB,
GATA2, and FLI1) was upregulated, whereas expression of the
primitive streak genes MIXL1, EOMES, T, and MESP1 was
downregulated (Figure 3A). However, these cells retained high
expression levels of genes representing lateral plate/extraem-
bryonic mesoderm (FOXF1, BMP4, andWNT5A). Based on their
phenotypic features, gene expression profile, morphology, and
functional properties, we designated KbrA+P mesodermal cells
as HVMPs. These precursors may resemble embryonic angio-
blasts, which are defined as cells that have not yet formed
a lumen and express certain (but not all) endothelial markers.
They are committed to differentiate into endothelial cells and
give rise to vascular primordia (Risau and Flamme, 1995).
BL-CFCs Represent Angiohematopoietic Progenitors
with Primitive Hematopoietic Potential Originating
from EMHlinAPLNR+PDGFRa+ Mesoderm
Blast CFCs (BL-CFCs) were identified by the Keller group as
progenitors that generate blast colonies composed of cells
with hematopoietic and endothelial potential (Choi et al., 1998).
Widely referred to as HBs, BL-CFCs represent the earliest cells
with detectable hematopoietic potential in mouse and human
ESC differentiation systems (Choi et al., 1998; Kennedy et al.,
2007). However, the exact position of HBs (BL-CFCs) within
the hierarchy of human angiohematopoietic cells and their devel-
opmental potential remains unclear. Various studies have
described BL colonies from differentiated hESCs at early stages
of mesodermal development (Davis et al., 2008; Kennedy et al.,
2007), as well as from cells at more advanced stages of differen-
tiation, including cells already expressing endothelial markers
(Lu et al., 2008; Zambidis et al., 2008). Moreover, two types of
HB colonies (one with and one without myeloid potential) were
recently described (Kennedy et al., 2007).
We previously demonstrated that BL-CFCs arise from a
day 2–3 EMHlinAPLNR+PDGFRa+ (A+P+) mesodermal popula-
tion that expresses genes associated with primitive streak and
lateral plate/extraembryonic mesoderm development reminis-(C) Endothelial and hematopoietic differentiation potential of indicated day 4
(bar = 20 mm). Endothelial culture panels show (ii) phase-contrast images (bar = 4
(bar = 400 mm) by KbrA+P cells. (v) Phase-contrast image of KbrA+P cell cultur
subsets after secondary OP9 coculture. Hematopoietic CFC potential of KDR su
GF+ serum-containing MethoCult. Error bars are means ± SE of three experimen
(D) Confocal images of hematoendothelial clusters to demonstrate the early stag
(E) A single-cell deposition assaywas used to detect the frequency of endothelial (E
KbrA+P HVMPs. The graph shows the frequency of each type of progenitor as a
bars are means ± SE of three experiments.
See also Figure S5.
Celcent of primitive posterior mesoderm (PM) in the embryo (Vodya-
nik et al., 2010). We showed that BL-CFCs could be detected
using serum-free FGF2-containing clonogenic medium (Vodya-
nik et al., 2010). Here, we also found that we could increase
the number of BL-CFCs by adding the APLNR ligand apelin-12
to the clonogenic medium (Figure 5B). Although hematopoietic
cytokines are commonly added to BL-CFC clonogenic medium,
we avoided using them in our assay so that we could increase its
specificity by eliminating false-positive results due to the detec-
tion of hematopoietic progenitors. Using an optimized BL-CFC-
specific assay with FGF2 and apelin-12, we detected BL-CFC
activity almost exclusively in day 3 A+P+ cells (Figure 5F), indi-
cating that HBs (BL-CFCs) are distinct from day 4 HVMPs and
day 5 HEPs and AHPs.
To characterize the developmental potential of BL-CFCs, we
analyzed the mature BL colonies using flow cytometry and
hematopoietic CFC assay. As shown in Figure 5A, HB (BL)
colonies collected on day 12 of clonogenic culture consisted
almost entirely of CD235a and/or CD41a expressing cells with
erythroblast morphology. In contrast to erythroid colonies gener-
ated from V+73235 HEPs, BL-CFCs expressed no adult
b hemoglobin (Figure 5C). The replating of 20 individual blast
colonies into serum-free hematopoietic clonogenic medium
demonstrated that they could give rise to erythroid, megakaryo-
cyte, and macrophage colonies, and mixed colonies composed
of all three cell types (Figures 5D and 5E). When a pool of 200
blast colonies was collected, we were able to detect the same
spectrum of hematopoietic CFCs. The spectra of hematopoietic
CFCs were similar when BL-CFCs were replated into standard
serum-containing hematopoietic CFC medium, although we
observed a reduction in the number of erythroid colonies and
a slight increase in macrophage colonies (not shown). These
results indicate that BL-CFC hematopoietic potential is mostly
restricted to primitive cells of erythromegakaryocytic andmacro-
phage lineages.
As previously demonstrated, BL-CFCs represent single-cell-
derived clonogenic progenitors that generate hematopoietic
cells through the formation of an endothelial intermediate (Lan-
crin et al., 2009; Vodyanik et al., 2010). This transitional interme-
diate appeared as a core-like structure that formed during the
first 3 days of clonogenic culture (Figure 5A) and distinguished
HB colonies from FGF2-dependent hematopoietic colonies
formed from day 5 AHPs (Figure S6A). HB cores were formed
by epithelioid cells, which stained positively for VE-cadherin.
However, in contrast to the membranous VE-cadherin expres-
sion typically seen in mature endothelial cells, VE-cadherin
expression in the HB core cells was predominantly cytoplasmic.
When HB cores were cultured in endothelial conditions, up tomesodermal subsets. (i) Wright-stained cytospins of freshly isolated cells
00 mm), (iii) immunofluorescent analysis (bar = 100 mm), and (iv) tube formation
es on OP9. Flow cytometric analysis shows a developmental potential of KDR
bsets was evaluated after secondary coculture on OP9 using standard H4435
ts.
es of endothelial-hematopoietic transition; bar = 50 mm.
), hematopoietic (H), and bipotential hematoendothelial (HE) progenitors within
percentage of cluster-containing wells versus total cell-deposited wells. Error
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Figure 5. Characterization of BL-CFCs
(A) Hematopoietic and endothelial potential of HB colonies selected at day 3 (core stage; bar = 50 mm) and day 12 (mature blast colony; bar = 100 mm) of
clonogenic culture. Top panels show (i) Wright-stained cytospins (bar = 100 mm), (ii) VE-cadherin and AcLDL staining (bar = 50 mm), (iii) endothelial culture (bar =
100 mm), and (iv) OP9 coculture (bar = 100 mm) of HB cores. Left panels show (v) cytospins (bar = 20 mm) and (vi) flow cytometric analysis of mature HB colony.
(B) Effect of adding apelin-12 on BL colony formation. Error bars are means ± SE of six experiments.
(C) Flow cytometric analysis of expression of adult and embryonic hemoglobins in HB colonies and erythroid colonies derived from V+73235 HEPs after
coculture on OP9.
(D) Morphology of typical hematopoietic colonies generated from day 12 BL colonies after they were replated into H4436 serum-free methylcellulose clonogenic
medium containing hematopoietic cytokines; bars = 200 mm.
(E) Frequency of formation of hematopoietic colonies after HB colonies were replated into serum-free hematopoietic CFCmedium. Left panel: Results of replating
20 individual colonies; error bars are means ± SE of three experiments. Right panel: Results of replating 200 blast colonies.
(F)BL-CFCpotential of the indicatedcell subsetsdetectedusingFGF2-andapelin12-containingclonogenicmedium.Errorbars representSEsof threeexperiments.
See also Figure S6.
562 Cell Reports 2, 553–567, September 27, 2012 ª2012 The Authors
95% of them generated typical VE-cadherin+ endothelial clus-
ters that were capable of incorporating AcLDL efficiently.
When the HB cores were collected and cultured on OP9 with
hematopoietic cytokines, they generated hematoendothelial
clusters (Figure 5A).
Molecular profiling studies demonstrated that HB cores had
a gene expression profile very similar to that of day 5 HEPs,
although the HB cores had much lower expression of RUNX1
gene associated with definitive hematopoiesis compared with
day 5 HEPs (Figures 3A and S4B). Together, these studies
indicate that BL-CFCs originate from the more-primitive A+P+
PM and reflect the first wave of yolk sac hematopoiesis, which
proceeds through the endothelial intermediate stage with
restricted erythroid,megakaryocytic, andmacrophage potential.
To find out whether the hematopoietic potential of A+P+ PM is
restricted to primitive HB-derived hematopoiesis or these cells
contain precursors of definitive angiohematopoietic progenitors,
we isolated day 2.5 A+P+ cells and recultured them on OP9. At
this stage, KbrA+P cells were not detected. As shown in Fig-
ure S6B, A+P+ cells rapidly expanded on OP9 and generated
the entire spectrum of angiohematopoietic and hematopoietic
progenitors, which we typically observed in primary hESC/OP9
coculture. These data indicate that A+P+ PM contains precursors
for both primitive and definitive hematopoiesis. Although matu-
ration of primitive angiohematopoietic progenitors was achieved
in serum-free semisolid medium in the presence of FGF2,
stromal factors were essential for the maturation of definitive
type angiohematopoietic progenitors from A+P+ PM.
Hematoendothelial Development from iPSCs
To determine whether other hPSC lines follow patterns of hema-
toendothelial differentiation similar to those observed with H1
hESC, we analyzed the development of newly identified subsets
of angiohematopoietic progenitors from transgene-free fibro-
blast-derived hiPSCs (Yu et al., 2009) and H9 hESCs. As shown
in Figure S7, all examined hPSC lines formed phenotypically and
functionally similar subsets of progenitors, including day 4
HVMPs, day 5 HEPs, AHPs, and non-HEPs.
DISCUSSION
During the last decade, investigators have made significant
progress in identifying the major stages of hematopoietic devel-
opment from hESCs/iPSCs (Kennedy et al., 2007; Vodyanik
et al., 2006; Zambidis et al., 2005) and their differentiation toward
particular blood lineages (Choi et al., 2009b; Lu et al., 2008; Oliv-
ier et al., 2006; Timmermans et al., 2009; Woll et al., 2005).
However, the development of cells with hematopoietic reconsti-
tution potential from ESC/iPSCs remains a challenge. Although
several studies showed bone marrow engraftment of differenti-
ated human ESCs and iPSCs, the engraftment rates were low
and mostly restricted to myeloid cells (Ledran et al., 2008; Lu
et al., 2009; Narayan et al., 2006; Risuen˜o et al., 2012; Tian
et al., 2006; Wang et al., 2005). The most likely explanation for
these findings is that in vitro conditions do not support the forma-
tion of HSC from its direct HE precursor. Thus, it is essential to
access awell-defined population ofHE cells to develop an in vitro
system that will enable identification of the critical factors thatCelcontrol the maturation of engraftable hematopoietic cells from
endothelium.
Previous studies demonstrated that cells expressing endothe-
lial molecules differentiated from mouse and human ESCs can
generate blood cells (Eilken et al., 2009; Hashimoto et al.,
2007; Nishikawa et al., 1998; Vodyanik et al., 2006; Wang
et al., 2004). It was also shown that HE can be prospectively
separated from non-HE in mouse ESC cultures based on the
activity of the Flk1 promoter/enhancer (Hirai et al., 2003). Here,
we demonstrate that the CD73 phenotypic marker can be used
to separate HE cells from non-HEPs prospectively. Of impor-
tance, we also found that the VE-cadherin+CD41aCD45 pop-
ulation in hPSC cultures includes CD235a+ (Glycophorin A+)
hematopoietic progenitors, which retain angiogenic potential.
On the basis of these findings, we were able to further specify
the phenotype of HEPs as VE-cadherin+CD73CD235a/CD43
and demonstrate that HEPs represent a transient population
of endothelial cells that emerge immediately after the beginning
of endotheliogenesis in hPSC cultures and rapidly decline
within next 3 days of differentiation. These HEPs have the
potential to generate b-hemoglobin-producing red blood cells
and the entire spectrum of myeloid progenitors, including
pan-myeloid GEMM progenitors, which have been identified in
human embryonic tissues but not the yolk sac (Hann et al.,
1983; Huyhn et al., 1995). Although other investigators and
our group previously demonstrated that CD34+CD43+ progeni-
tors generated in hPSC/OP9 coculture have T and B lymphoid
potential (Carpenter et al., 2011; Timmermans et al., 2009;
Vodyanik et al., 2005, 2006), further studies will be required to
prove that CD34+CD43+ cells with lymphoid potential arise
directly from HEPs.
By analyzing the expression of mesodermal markers at stages
preceding endotheliogenesis, we identified EMHlinKDRbright
APLNR+PDGFRalow/ HVMPs as the direct precursors of defini-
tive-type HEPs. The HVMPs and HEPs required stromal factors
for hematopoietic development and were distinct from HBs,
which arise from day 3 A+P+ PM cells and can be specifically de-
tected in serum-free semisolid medium in the presence of FGF2
and apelin-12. The hematopoietic potential of HB colonies
detected using these conditions was mostly restricted to cells
of erythromegakaryocytic lineage, reflecting the first wave of
hematopoiesis observed in the yolk sac. These results are also
consistent with mouse studies that demonstrated that Flk1-
positive hemangioblastic cells are mainly primitive hematopoi-
etic cells (Fehling et al., 2003). Hematopoietic cells within HB
colonies arise through core-forming VE-cadherin+ cells that, in
contrast to definitive angiohematopoietic progenitors, develop
in serum-free medium without stromal support. HB cores have
an endothelial gene expression profile and potential. However,
our finding that HB cores express intracellular rather than
membranous VE-cadherin indicates that they are different from
definitive HEPs, and may represent a distinct type of immature
cells of endothelial lineage that are more similar to angioblastic
mesodermal cells than to more mature endothelial cells that
line already established blood vessels. VE-cadherin+ cells that
coexpress CD31, CD34, CD105, and TEK endothelial markers
were previously identified within a subset of Flk1-positive cells
in the extraembryonic mesoderm region during gastrulationl Reports 2, 553–567, September 27, 2012 ª2012 The Authors 563
and yolk sac blood islands in embryonic day 7.0–7.5 mouse
embryos (Ema et al., 2006; Yokomizo et al., 2007). These cells
were able to generate endothelial and primitive blood cells.
Because HB cores have similar phenotypic and functional
characteristics, they could be equivalent to the VE-cadherin+
cells detected within the Flk1+ extraembryonic compartment.
Our study reveals a unique population of AHPs that express
VE-cadherin and glycophorin A (CD235a) erythroid marker but
lack CD41a. These AHPs represent multipotential hematopoietic
progenitors that, similarly to BL-CFCs (HBs), require serum-free
conditions and FGF2 for colony formation. However, in contrast
to BL-CFCs, the development of colonies from AHPs depends
on hematopoietic cytokines and does not proceed through an
endothelial core stage. Another unique feature of AHPs is their
angiogenic capability, which is completely lost in CD235a+
CD41a+ cells that arise at later stages of differentiation. FGF2-
and hematopoietic cytokine-dependent colonies with and
without endothelial potential have been described in the mouse
yolk sac, fetal liver, and AGM (He et al., 2010; Yao et al., 2007),
indicating that AHPs may have in vivo counterparts. Given the
fact that AHP cells express a definitive hematopoiesis transcrip-
tional factor, RUNX1 (Figures 4 and S4B), and possess erythroid
and uni- and multilineage myeloid differentiation potential, they
may represent precursors for a transient wave of definitive eryth-
romyeloid hematopoiesis similar to the one described in mouse
yolk sac (Palis et al., 1999).
In addition, our studies provide important insight into endothe-
lial development from hESCs. Although one commonly held view
implies that all endothelial cells in PSC cultures originate from
HBs, our current and prior studies (Vodyanik et al., 2010) are in
agreement with other studies (Era et al., 2008) that indicate
that PSCs give rise to multiple types of endothelial progenitors.
Of importance, we demonstrated that emerging endothelial
progenitors are multipotent and are able to differentiate into cells
of other mesodermal lineages. The first progenitors with endo-
thelial potential, the mesenchymoangioblasts, arise from PSCs
on day 2 of differentiation and are capable of forming mesen-
chymal colonies (Vodyanik et al., 2010). HBs capable of gener-
ating primitive blood cells through endothelial intermediates in
semisolid medium arise 1 day later. Endothelial intermediates
that form HB colonies most likely resemble the yolk sac HE.
HEPs that develop by day 5 in hPSC/OP9 coculture express
RUNX1 and have the potential to generatemultipotential myeloid
cells and b-globin-producing erythroid cells, and thus resemble
definitive-type endothelial progenitors. Non-HEPs were distinc-
tively recognized by the expression of CD73 (Figure 6).
CD73 (also known as 50-ectonucleotidase) is a glycosylphos-
phatidylinositol (GPI)-linked 70 kDa glycoprotein that produces
extracellular adenosine and is abundantly expressed by endo-
thelial cells, mesenchymal stem cells, subsets of peripheral
blood lymphocytes, and a variety of other tissues (Delorme et al.,
2008; Thomson et al., 1990). CD73 is involved in the regulation of
vascular permeability and maintenance of the barrier function,
adaptation to hypoxia, ion and fluid transport, and regulation of
inflammatory responses in the extracellular milieu (Colgan
et al., 2006). Given the physiological significance of CD73, it is
likely that expression of this molecule reflects differences not
only in the developmental potential but also the functional prop-564 Cell Reports 2, 553–567, September 27, 2012 ª2012 The Authorerties of HE and non-HE subsets. Other distinctive features of
CD73+ non-HEP were the lack of CD226 hematopoietic marker
expression and the strong expression of CD117 (c-KIT). CD117
is known to mark HSCs arising from the AGM, and is also found
in CD45CD31+ circulating endothelial progenitors and cardiac
endothelial progenitors (Peichev et al., 2000; Sandstedt et al.,
2010; Tallini et al., 2009). The strong expression of CD117 and
the lack of hematopoietic potential in CD73+ endothelial cells
indicate that these cells represent a population of endothelial
progenitors that are distinct from blood-forming endothelial
progenitors and may resemble circulating or tissue-specific
endothelial progenitors. Whether these newly identified subsets
of endothelial cells possess distinct functional properties and
endothelial differentiation potential remains to be explored.
In conclusion, the identification of distinct subsets of cells with
angiohematopoietic potential in our studies provides an hPSC-
based platform for identifying molecular determinants of HSC
development with the goal of facilitating the generation of
HSCs from hPSCs.
EXPERIMENTAL PROCEDURES
The experimental procedures used in this study are briefly described below.
The Supplemental Information contains a complete description.
Maintenance of hPSCs
H1 and H9 hESC lines were obtained fromWiCell Research Institute (Madison,
WI). H9-EGFP (Xia et al., 2008) was kindly provided by Su-Chun Zhang (Univer-
sity of Wisconsin, Madison, WI). Transgene-free DF4-3-7T and DF19-9-7T
human iPSC cell lines were produced using episomal vectors (Yu et al.,
2009). All hESC/iPSC lines were maintained in an undifferentiated state on irra-
diated mouse embryonic fibroblasts as described previously (Yu et al., 2007).
hPSC Differentiation in OP9 Coculture
hESC/iPSCs were differentiated in coculture with OP9 stromal cells provided
by Dr. Toru Nakano (Osaka University, Osaka, Japan) and depleted of OP9
cells using anti-mouse CD29 antibodies (Serotec) as previously described
(Vodyanik et al., 2010).
Cell Sorting andAnalysis of Hematopoietic and Endothelial Potential
The approach and antibodies used to isolate distinct subsets of progenitors
with angiohematopoietic potential are summarized in Figure S2 and
Table S1. VE-cadherin+ or CD31+ cells were isolated from day 5 hESC/OP9
cocultures by positive MACS selection using the corresponding FITC-conju-
gated antibodies and anti-FITC magnetic beads (Miltenyi). MACS-separated
cells were stained with CD73-PE, CD235a-APC, and CD43-APC, and
CD41a-PECy7 antibodies and sorted using a FACSAria cell sorter (BD Biosci-
ences) to select subsets as depicted in Figures 1B and S2. To isolate day 4
subsets from hPSC/OP9 cocultures, KDR-positive cells were selected by posi-
tive MACS selection using KDR-PE antibody (R&D Systems) and anti-PE
magnetic beads (Miltenyi). After labeling with VE-cadherin-APC antibody,
KDRbrightVE-cadherin, KDRdimVE-cadherin, and KDR cells were further
separated using the FACSAria sorter. APLNR+ cells were isolated from day 3
hESC/OP9 cocultures by MACS sorting with APLNR-APC antibodies and
APC-magnetic beads or FACSAria sorter after depletion of OP9 with anti-
mouse CD29 antibodies as previously described (Vodyanik et al., 2010). The
hematopoietic and endothelial potential of isolated cells was evaluated before
and after secondary coculture with OP9 via CFC assay, endothelial culture,
and flow cytometry (see Supplemental Information).
Statistical Tests
The significance of differences between the mean values was determined by
paired Student’s t test.s
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Figure 6. Distinct Stages of Angiohematopoietic Differentiation from hPSCs in Coculture with OP9
Coculture of hESC with OP9 induces mesendodermal differentiation. The first cells with angiohematopoietic potential arise within EMHlinAPLNR+PDGFRa+
mesoderm. These cells have the potential to form BL (HB) colonies, which can be specifically detected in serum-free semisolid medium containing FGF2 and
apelin. Development of BL colonies proceeds through a core stage in which mesodermal cells form clusters of tightly packed endothelial intermediates (cores).
Subsequently, core-forming endothelial cells give rise predominantly to primitive erythromegakaryocytic cells. Advanced mesodermal commitment of hESCs
toward hematoendothelial lineage in coculture with OP9 is associated with upregulation of KDR and downregulation of PDGFRa within the APLNR+ population,
and the development of HVMPs. These cells are highly enriched in bipotential hematoendothelial cluster-forming cells. After gaining VE-cadherin expression, the
cells gradually acquire an endothelial or hematopoietic cell morphology and gene expression profile. The earliest hematopoietic progenitors emerging within the
VE-cadherin+ population, AHPs, display a CD43lowCD235a+ phenotype and possess endothelial and FGF2-dependent erythromyeloid potential. Expression of
CD73 within the VE-cadherin+CD235a/CD43 population discriminates non-HEPs and HEPs. HEPs do not form hematopoietic CFCs in semisolid medium, but
are capable of generating the entire spectrum of definitive myeloid cells and b-globin-producing red blood cells when cultured on OP9. Progressive hemato-
poietic differentiation is associated with upregulation of CD43 expression, acquisition of CD41a and/or CD45 markers, and loss of endothelial potential. A similar
pattern of hematoendothelial development is observed in hiPSCs. See also Figure S7.ACCESSION NUMBERS
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